Filtros : "MIOSITE" "Itália" Removido: "Indexado no: CAB Abstracts" Limpar

Filtros



Refine with date range


  • Source: Reumatismo. Unidade: FM

    Subjects: DOENÇAS PULMONARES INTERSTICIAIS, MIOSITE, DOENÇAS AUTOIMUNES, AUTOANTICORPOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Fernando Henrique Carlos de et al. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review. Reumatismo, v. 75, n. 1, p. 1-14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53778. Acesso em: 01 nov. 2024.
    • APA

      Souza, F. H. C. de, Araujo, D. B. de, Hoff, L. S., Baldi, B. G., Faria, M. S. M. S., Rocha Júnior, L. F. da, et al. (2023). Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review. Reumatismo, 75( 1), 1-14. doi:10.4081/reumatismo.2023.1571
    • NLM

      Souza FHC de, Araujo DB de, Hoff LS, Baldi BG, Faria MSMS, Rocha Júnior LF da, Silva LRSD, Pinto GLB, Bezerra MC, Miossi R, Cordeiro RA, Shinjo SK. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review [Internet]. Reumatismo. 2023 ; 75( 1): 1-14.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53778
    • Vancouver

      Souza FHC de, Araujo DB de, Hoff LS, Baldi BG, Faria MSMS, Rocha Júnior LF da, Silva LRSD, Pinto GLB, Bezerra MC, Miossi R, Cordeiro RA, Shinjo SK. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review [Internet]. Reumatismo. 2023 ; 75( 1): 1-14.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53778
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: ESTIMULAÇÃO MAGNÉTICA TRANSCRANIANA, MIOSITE, DOENÇAS AUTOIMUNES, ESTUDOS PROSPECTIVOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUSA, Luiz Felipe Adsuara de et al. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial. Clinical and experimental rheumatology, v. 41, n. 2, p. 221-229, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53894. Acesso em: 01 nov. 2024.
    • APA

      Sousa, L. F. A. de, Misse, R. G., Santos, L. M. dos, Tanaka, C., Greve, J. M. D. 'A., Baptista, A. F., & Shinjo, S. K. (2023). Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial. Clinical and experimental rheumatology, 41( 2), 221-229. Recuperado de https://observatorio.fm.usp.br/handle/OPI/53894
    • NLM

      Sousa LFA de, Misse RG, Santos LM dos, Tanaka C, Greve JMD'A, Baptista AF, Shinjo SK. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 221-229.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53894
    • Vancouver

      Sousa LFA de, Misse RG, Santos LM dos, Tanaka C, Greve JMD'A, Baptista AF, Shinjo SK. Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 221-229.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53894
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: DOENÇAS MUSCULARES, MIOSITE, PREVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Lila Morena Bueno e BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome. Clinical and experimental rheumatology, v. 41, n. 2, p. 238-246, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53775. Acesso em: 01 nov. 2024.
    • APA

      Silva, L. M. B., Borges, I. B. P., & Shinjo, S. K. (2023). High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome. Clinical and experimental rheumatology, 41( 2), 238-246. doi:10.55563/clinexprheumatol/zq7x68
    • NLM

      Silva LMB, Borges IBP, Shinjo SK. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 238-246.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53775
    • Vancouver

      Silva LMB, Borges IBP, Shinjo SK. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 238-246.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53775
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: MIOSITE, DERMATOPATIAS, AUTOANTICORPOS, DOENÇAS PULMONARES INTERSTICIAIS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PALLO, Pablo Arturo Olivo e SHINJO, Samuel Katsuyuki. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis. Clinical and experimental rheumatology, v. 41, n. 2, p. 394-394, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53776. Acesso em: 01 nov. 2024.
    • APA

      Pallo, P. A. O., & Shinjo, S. K. (2023). Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis. Clinical and experimental rheumatology, 41( 2), 394-394. Recuperado de https://observatorio.fm.usp.br/handle/OPI/53776
    • NLM

      Pallo PAO, Shinjo SK. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 394-394.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53776
    • Vancouver

      Pallo PAO, Shinjo SK. Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis [Internet]. Clinical and experimental rheumatology. 2023 ; 41( 2): 394-394.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53776
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: DERMATOPATIAS, DOENÇAS AUTOIMUNES, MIOSITE

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CORDEIRO, R. A e FISCHER, F. M e SHINJO, Samuel Katsuyuki. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, v. 40, n. 2, p. 339-345, 2022Tradução . . Disponível em: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV. Acesso em: 01 nov. 2024.
    • APA

      Cordeiro, R. A., Fischer, F. M., & Shinjo, S. K. (2022). Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, 40( 2), 339-345. doi:10.55563/CLINEXPRHEUMATOL/KEIEDV
    • NLM

      Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 nov. 01 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
    • Vancouver

      Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 nov. 01 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
  • Source: Reumatismo. Unidade: FM

    Subjects: COVID-19, REUMATOLOGIA, MIOSITE, INFLAMAÇÃO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FARIA, M. S. M. S e SHINJO, Samuel Katsuyuki. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, v. 74, n. 1, p. 41-43, 2022Tradução . . Disponível em: https://doi.org/10.4081/reumatismo.2022.1440. Acesso em: 01 nov. 2024.
    • APA

      Faria, M. S. M. S., & Shinjo, S. K. (2022). COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, 74( 1), 41-43. doi:10.4081/reumatismo.2022.1440
    • NLM

      Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
    • Vancouver

      Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
  • Source: Reumatismo. Unidade: FM

    Subjects: DOENÇAS MUSCULARES, ATROFIA MUSCULAR, MIOSITE, CURVATURAS DA COLUNA VERTEBRAL

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAUJO, C. S. R. et al. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo, v. 73, n. 2, p. 122-130, 2021Tradução . . Disponível em: https://doi.org/10.4081/reumatismo.2021.1397. Acesso em: 01 nov. 2024.
    • APA

      Araujo, C. S. R., Miossi, R., Souza, F. H. C. de, Costa, M. D., Silva, A. M. S. da, Campos, E. D., et al. (2021). Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo, 73( 2), 122-130. doi:10.4081/reumatismo.2021.1397
    • NLM

      Araujo CSR, Miossi R, Souza FHC de, Costa MD, Silva AMS da, Campos ED, Zanoteli E, Shinjo SK. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature [Internet]. Reumatismo. 2021 ; 73( 2): 122-130.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4081/reumatismo.2021.1397
    • Vancouver

      Araujo CSR, Miossi R, Souza FHC de, Costa MD, Silva AMS da, Campos ED, Zanoteli E, Shinjo SK. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature [Internet]. Reumatismo. 2021 ; 73( 2): 122-130.[citado 2024 nov. 01 ] Available from: https://doi.org/10.4081/reumatismo.2021.1397
  • Source: Clinical and experimental rheumatology. Unidades: FM, EEFE

    Subjects: TREINAMENTO FÍSICO, CAPACIDADE AERÓBICA, FORÇA MUSCULAR, MIOSITE, DOENÇAS NEUROMUSCULARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Jean Marcos de et al. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology, v. 37, n. 2, p. 235-241, 2019Tradução . . Acesso em: 01 nov. 2024.
    • APA

      Souza, J. M. de, Roschel, H., Lima, F. R., Shinjo, S. K., Oliveira, D. S. de, Perin, L. A., et al. (2019). Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology, 37( 2), 235-241.
    • NLM

      Souza JM de, Roschel H, Lima FR, Shinjo SK, Oliveira DS de, Perin LA, Misse RG, Santos AM dos, Gualano B, Sá Pinto AL de. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology. 2019 ; 37( 2): 235-241.[citado 2024 nov. 01 ]
    • Vancouver

      Souza JM de, Roschel H, Lima FR, Shinjo SK, Oliveira DS de, Perin LA, Misse RG, Santos AM dos, Gualano B, Sá Pinto AL de. Feasibility, safety and efficacy of exercise training in immune-mediated necrotizing myopathies: a quasi-experimental prospective study. Clinical and experimental rheumatology. 2019 ; 37( 2): 235-241.[citado 2024 nov. 01 ]
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: INTERLEUCINAS, MIOSITE, DERMATOPATIAS, ESTUDOS TRANSVERSAIS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, M. G et al. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, v. 37, n. 4, p. 656-662, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33118. Acesso em: 01 nov. 2024.
    • APA

      Silva, M. G., Shinjo, S. M. O., Marie, S. K. N., & Shinjo, S. K. (2019). Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, 37( 4), 656-662. Recuperado de http://observatorio.fm.usp.br/handle/OPI/33118
    • NLM

      Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
    • Vancouver

      Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 01 nov. 2024.
    • APA

      Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488
    • NLM

      Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
    • Vancouver

      Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024